Gene · 10521
NIH grants1,197
NIH grants whose papers are about the gene, through NIH's grant-paper links.
761 to 780 of 1,197
Download this page as JSON| Grant | Title | DDX17 papers | Newest fiscal year |
|---|---|---|---|
| R00CA160350 | Nanoparticle Co-delivery of RNAi and Chemotherapy for Multidrug Resistant Cancers | 1 | 2015 |
| R01AI088011 | The role of non-canonical base pairs in RNA editing | 1 | 2015 |
| R01AI089713 | Pathophysiology of cholangiocyte responses to microbial pathogens | 1 | 2015 |
| R01AI094474 | Development of a novel drug candidate that inhibits hepatitis B virus covalently | 1 | 2015 |
| R01CA037393 | Modulators of Prostate Cancer Metastasis | 1 | 2015 |
| R01CA131250 | The role of Twist in inducing breast cancer initiating cells and metastasis | 1 | 2015 |
| R01CA132809 | Regulation and function of the YAP transcription co-activator oncoprotein | 1 | 2015 |
| R01CA140875 | Mouse Models to Dissect p53 Tumor Suppressor Function | 1 | 2015 |
| R01CA149109 | The role of microRNAs in leukemic initiation and maintenance | 1 | 2015 |
| R01CA149655 | Mechanisms of T cell leukemia induction and maintenance | 1 | 2015 |
| R01CA151319 | TOWARD AN UNDERSTANDING OF CLL PROGRESSION | 1 | 2015 |
| R01CA151564 | Regulation of TRAIL Induced Apoptosis in Cancer Cells | 1 | 2015 |
| R01CA154725 | Multi-scale Molecular Imaging of the Degradome in Breast Tumors | 1 | 2015 |
| R01CA154767 | Elucidating the function of the widely inactivated phosphatase PTPRD in the molec | 1 | 2015 |
| R01CA158283 | Modulation of VEGF-A alternative splicing as new anti-angiogenic therapeutics | 1 | 2015 |
| R01CA164346 | CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF | 1 | 2015 |
| R01CA177423 | KSHV genome modification in KS tissue | 1 | 2015 |
| R01DK062248 | The Functional Analysis of the Coactivator CARM1 | 1 | 2015 |
| R01DK075972 | The Role of Basa Bodies in Wnt Signaling | 1 | 2015 |
| R01ES017080 | Novel Strategies to Identify GxE Contributions to MS Pathogenesis | 1 | 2015 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10521/grants?page=39